Federal contractor profile
FLAG BIO, INC
UEI LZTAN53LY9V9CAGE 9A3C6
Overview
- Legal name
- FLAG BIO, INC
- Registered location
- EAST AURORA, NY, USA
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Aug 22, 2024
Read company summary
FLAG BIO, INC is associated with UEI LZTAN53LY9V9 and CAGE 9A3C6 in public federal records. AcornBids currently links 1 prime award totaling $594.6K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists EAST AURORA, NY, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- FLAG BIO, INC
- UEI
- LZTAN53LY9V9
- CAGE
- 9A3C6
- Registered address
- 1892 SWEET RD, EAST AURORA, NY, 14052, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Feb 6, 2026
- Initial registration
- Mar 23, 2022
- Entity start
- Feb 23, 2022
- SAM updated
- Feb 6, 2026
- Registration expires
- Feb 4, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N93024C00014MRNA VACCINE DEVELOPMENT | Department of Health and Human Services | $594.6K | Sep 1, 2024 | Aug 31, 2026 |
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Feb 6, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Mar 23, 2022 |
| Entity start | Feb 23, 2022 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| ILYA GITLIN | Government business | Contact method not published | SAM registration | Not available |
| ILYA GITLIN | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit